These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28597024)

  • 1. Blocking mTOR Signalling with Rapamycin Ameliorates Imiquimod-induced Psoriasis in Mice.
    Bürger C; Shirsath N; Lang V; Diehl S; Kaufmann R; Weigert A; Han YY; Ringel C; Wolf P
    Acta Derm Venereol; 2017 Oct; 97(9):1087-1094. PubMed ID: 28597024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.
    Chamcheu JC; Adhami VM; Esnault S; Sechi M; Siddiqui IA; Satyshur KA; Syed DN; Dodwad SM; Chaves-Rodriquez MI; Longley BJ; Wood GS; Mukhtar H
    Antioxid Redox Signal; 2017 Jan; 26(2):49-69. PubMed ID: 27393705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin ameliorates psoriasis by regulating the expression and methylation levels of tropomyosin via ERK1/2 and mTOR pathways in vitro and in vivo.
    Gao M; Si X
    Exp Dermatol; 2018 Oct; 27(10):1112-1119. PubMed ID: 30019485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical application of rapamycin ointment ameliorates Dermatophagoides farina body extract-induced atopic dermatitis in NC/Nga mice.
    Yang F; Tanaka M; Wataya-Kaneda M; Yang L; Nakamura A; Matsumoto S; Attia M; Murota H; Katayama I
    Exp Dermatol; 2014 Aug; 23(8):568-72. PubMed ID: 24903639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian target of rapamycin and its downstream signalling components are activated in psoriatic skin.
    Buerger C; Malisiewicz B; Eiser A; Hardt K; Boehncke WH
    Br J Dermatol; 2013 Jul; 169(1):156-9. PubMed ID: 23398394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis.
    Schaper K; Dickhaut J; Japtok L; Kietzmann M; Mischke R; Kleuser B; Bäumer W
    J Dermatol Sci; 2013 Jul; 71(1):29-36. PubMed ID: 23643308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells.
    Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P
    Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mammalian target of rapamycin signalling pathway is involved in osteoblastic differentiation of vascular smooth muscle cells.
    Zhan JK; Wang YJ; Wang Y; Wang S; Tan P; Huang W; Liu YS
    Can J Cardiol; 2014 May; 30(5):568-75. PubMed ID: 24518659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
    Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
    J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
    Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
    J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic target of rapamycin small interfering RNA and rapamycin synergistically inhibit tumour growth in a mouse xenograft model of human oesophageal carcinoma.
    Sun MM; Zhang MZ; Chen Y; Li SL; Zhang W; Ya GW; Chen KS
    J Int Med Res; 2012; 40(5):1636-43. PubMed ID: 23206445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells.
    Weichhart T; Haidinger M; Katholnig K; Kopecky C; Poglitsch M; Lassnig C; Rosner M; Zlabinger GJ; Hengstschläger M; Müller M; Hörl WH; Säemann MD
    Blood; 2011 Apr; 117(16):4273-83. PubMed ID: 21368289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation.
    Zhao Y; Zhao MM; Cai Y; Zheng MF; Sun WL; Zhang SY; Kong W; Gu J; Wang X; Xu MJ
    Kidney Int; 2015 Oct; 88(4):711-21. PubMed ID: 26061549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin (Sirolimus) alters mechanistic target of rapamycin pathway regulation and microRNA expression in mouse meiotic spermatocytes.
    Mukherjee A; Koli S; Reddy KV
    Andrology; 2015 Sep; 3(5):979-90. PubMed ID: 26311343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex.
    Rensing N; Han L; Wong M
    Epilepsia; 2015 Jul; 56(7):1088-97. PubMed ID: 26122303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway.
    Lee KW; Yook JY; Son MY; Kim MJ; Koo DB; Han YM; Cho YS
    Stem Cells Dev; 2010 Apr; 19(4):557-68. PubMed ID: 19642865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mTOR by Rapamycin Aggravates Corneal Epithelial Stem Cell Deficiency by Upregulating Inflammatory Response.
    Park JW; Ko JH; Kim BH; Ryu JS; Kim HJ; Kim MK; Oh JY
    Stem Cells; 2019 Sep; 37(9):1212-1222. PubMed ID: 31102490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis.
    Huber S; Bruns CJ; Schmid G; Hermann PC; Conrad C; Niess H; Huss R; Graeb C; Jauch KW; Heeschen C; Guba M
    Kidney Int; 2007 Apr; 71(8):771-7. PubMed ID: 17299523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.
    Nguyen LH; Brewster AL; Clark ME; Regnier-Golanov A; Sunnen CN; Patil VV; D'Arcangelo G; Anderson AE
    Epilepsia; 2015 Apr; 56(4):636-46. PubMed ID: 25752454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive effect of β, β-dimethylacryloyl alkannin on activated dendritic cells in an imiquimod-induced psoriasis mouse model.
    Wang Y; Zhao J; Zhang L; Di T; Liu X; Lin Y; Zeng Z; Li P
    Int J Clin Exp Pathol; 2015; 8(6):6665-73. PubMed ID: 26261548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.